Johan van Walsem, Metabolix COO, has been leading the wind down of the company's
biopolymer operations and transfer of
biopolymer assets to CJ CheilJedang.
With the new space in Woburn, we will be able to upgrade and expand our
biopolymer applications development lab to support customer projects as we continue to ramp up our PHA [polyhydroxyalkanoate]
biopolymer market development activities and work to transition from pilot scale to commercial scale operations.
US-based industrial biotechnology company TerraVerdae BioWorks has entered into a strategic partnership agreement with PolyFerm Canada, a Canadian
biopolymer company focused on developing renewable and biodegradable alternatives to petrochemical-based elastomers, the company said.
Delivery systems consisting of lipid droplets encapsulated by nano-laminated
biopolymer coatings have potential, but there is some concern about the bioavailability of the encapsulated lipids.
They describe
biopolymer modification methods to enhance the compatibility, flexibility, enhanced physicochemical properties, thermal stability, impact response, and rigidity of materials like chitosan, agar-based graft copolymers, lignocellulose fibers, degradable poly(3-hydroxyalkanoates), starches, natural fibers, and cellulose nanocrystals, and tissue engineering and drug delivery, biomedical and environmental, biological, food and non-food, and other applications.
The buzz was about Wintershall's research project about the
biopolymer Schizophyllan.
Chitin is a
biopolymer that comprises a linear sequence of monomeric sugars of Nacetylglucosamine.
Among the topics are
biopolymers from plants, bacterial
biopolymers and genetically engineered
biopolymers for gel systems applications, associating
biopolymer systems and hyaluronate biomaterials, and conformation and rheology of microbial exopolysaccharides.
Adding the Vigido know-how to FMC's newly acquired pectin business provides FMC
BioPolymer with enhanced ability to serve a wide range of low pH food applications.
Neurotrauma treatment company InVivo Therapeutics Holdings Corp (OTC BB :NVIV) revealed on Friday that it ha received approval to begin human studies to test its
biopolymer scaffold product technology to treat patients with acute, traumatic Spinal Cord Injury (SCI).
In addition, biocompatibility of the
biopolymer material is questionable because of the release of toxic components from some of the crosslinkers upon usage.
